63 related articles for article (PubMed ID: 9367638)
1. Reduction in fibronectin expression and alteration in cell morphology are coincident in NIH3T3 cells expressing a mutant E2F1 transcription factor.
Jordan-Sciutto KL; Logan TJ; Norton PA; Derfoul A; Dodge GR; Hall DJ
Exp Cell Res; 1997 Nov; 236(2):527-36. PubMed ID: 9367638
[TBL] [Abstract][Full Text] [Related]
2. Altered cell shape is linked to increased p34cdc2 gene expression in fibroblasts expressing a mutant E2F-1 transcription factor.
Logan TJ; Jordan KL; Evans DL; Hall DJ
J Cell Biochem; 1997 Apr; 65(1):83-94. PubMed ID: 9138083
[TBL] [Abstract][Full Text] [Related]
3. Expression of a deletion mutant of the E2F1 transcription factor in fibroblasts lengthens S phase and increases sensitivity to S phase-specific toxins.
Logan TJ; Evans DL; Mercer WE; Bjornsti MA; Hall DJ
Cancer Res; 1995 Jul; 55(13):2883-91. PubMed ID: 7540951
[TBL] [Abstract][Full Text] [Related]
4. An early S phase checkpoint is regulated by the E2F1 transcription factor.
Stubbs MC; Strachan GD; Hall DJ
Biochem Biophys Res Commun; 1999 Apr; 258(1):77-80. PubMed ID: 10222238
[TBL] [Abstract][Full Text] [Related]
5. A mutant E2F-1 transcription factor that affects the phenotype of NIH3T3 fibroblasts inefficiency associates with cyclin A-cdk2.
Jordan-Sciutto KL; Hall DJ
Biochem Cell Biol; 1998; 76(1):37-44. PubMed ID: 9666304
[TBL] [Abstract][Full Text] [Related]
6. Evidence for GEAPS, novel Glial E2F1-Associated Proteins in hamster glioma cells induced by the human neurotropic polyomavirus, JCV.
Raj GV; Ansari SA; Khalili K
Oncogene; 1996 Mar; 12(6):1279-88. PubMed ID: 8649830
[TBL] [Abstract][Full Text] [Related]
7. Poly(ADP-ribose) polymerase upregulates E2F-1 promoter activity and DNA pol alpha expression during early S phase.
Simbulan-Rosenthal CM; Rosenthal DS; Luo R; Smulson ME
Oncogene; 1999 Sep; 18(36):5015-23. PubMed ID: 10490838
[TBL] [Abstract][Full Text] [Related]
8. Isolation of two novel cDNAs whose products associate with the amino terminus of the E2F1 transcription factor.
Jordan KL; Evans DL; Steelman S; Hall DJ
Biochemistry; 1996 Sep; 35(38):12320-8. PubMed ID: 8823166
[TBL] [Abstract][Full Text] [Related]
9. Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F.
Hiyama H; Iavarone A; Reeves SA
Oncogene; 1998 Mar; 16(12):1513-23. PubMed ID: 9569018
[TBL] [Abstract][Full Text] [Related]
10. Cell growth-regulated expression of mammalian MCM5 and MCM6 genes mediated by the transcription factor E2F.
Ohtani K; Iwanaga R; Nakamura M; Ikeda M; Yabuta N; Tsuruga H; Nojima H
Oncogene; 1999 Apr; 18(14):2299-309. PubMed ID: 10327050
[TBL] [Abstract][Full Text] [Related]
11. Cyclin A levels, the duration of S phase and sensitivity to a chemotherapeutic agent are altered in fibroblasts cultured on a fibronectin matrix.
Min I; Stubbs MC; Strachan GD; Hall DJ
Int J Oncol; 1998 Sep; 13(3):549-55. PubMed ID: 9683792
[TBL] [Abstract][Full Text] [Related]
12. Deregulated expression of E2F1 induces hyperplasia and cooperates with ras in skin tumor development.
Pierce AM; Fisher SM; Conti CJ; Johnson DG
Oncogene; 1998 Mar; 16(10):1267-76. PubMed ID: 9546428
[TBL] [Abstract][Full Text] [Related]
13. E2F1 mediates ectopic proliferation and stage-specific p53-dependent apoptosis but not aberrant differentiation in the ocular lens of Rb deficient fetuses.
Liu Y; Zacksenhaus E
Oncogene; 2000 Dec; 19(52):6065-73. PubMed ID: 11146559
[TBL] [Abstract][Full Text] [Related]
14. Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex.
Hofland K; Petersen BO; Falck J; Helin K; Jensen PB; Sehested M
Clin Cancer Res; 2000 Apr; 6(4):1488-97. PubMed ID: 10778981
[TBL] [Abstract][Full Text] [Related]
15. In human salivary gland cells, overexpression of E2F1 overcomes an interferon-gamma- and tumor necrosis factor-alpha-induced growth arrest but does not result in complete mitosis.
Lillibridge CD; O'Connell BC
J Cell Physiol; 1997 Sep; 172(3):343-50. PubMed ID: 9284954
[TBL] [Abstract][Full Text] [Related]
16. Association of Pur alpha and E2F-1 suppresses transcriptional activity of E2F-1.
Darbinian N; Gallia GL; Kundu M; Shcherbik N; Tretiakova A; Giordano A; Khalili K
Oncogene; 1999 Nov; 18(46):6398-402. PubMed ID: 10597240
[TBL] [Abstract][Full Text] [Related]
17. Regulation of E2F-1 gene expression in avian cells.
Espanel X; Le Cam L; North S; Sardet C; Brun G; Gillet G
Oncogene; 1998 Aug; 17(5):585-94. PubMed ID: 9704924
[TBL] [Abstract][Full Text] [Related]
18. Association with E2F-1 governs intracellular trafficking and polyubiquitination of DP-1.
Magae J; Illenye S; Chang YC; Mitsui Y; Heintz NH
Oncogene; 1999 Jan; 18(3):593-605. PubMed ID: 9989809
[TBL] [Abstract][Full Text] [Related]
19. The p107 tumor suppressor induces stable E2F DNA binding to repress target promoters.
O'Connor RJ; Schaley JE; Feeney G; Hearing P
Oncogene; 2001 Apr; 20(15):1882-91. PubMed ID: 11313936
[TBL] [Abstract][Full Text] [Related]
20. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
Santoni-Rugiu E; Jensen MR; Thorgeirsson SS
Cancer Res; 1998 Jan; 58(1):123-34. PubMed ID: 9426068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]